Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 12:16 AM
NCT ID:
NCT00038558
Eligibility Criteria:
INCLUSION:
* Previously untreated Hodgkin's disease patients who are scheduled to receive standard ABVD chemo.
* Histologically proven diagnosis of Hodgkin's disease of any type.
* Bidimensionally measurable disease.
* Signed informed consent.
* Age \>/= 16 yrs.
* Adequate bone marrow reserve (ANC\>1000/uL, Platelet \>100,000/uL.
* LVEF\>/=50% by MUGA scan or echocardiogram.
* Serum creatinine \<2mg/dL; serum bilirubin\<2mg/dL.
EXCLUSION:
* HIV positive.
* Pregnant women and those of child bearing age who are not using adequate contraception.
* Prior chemotherapy.
* Severe pulmonary disease including COPD and asthma.
* History of prior sensitivity to E.coli derived products.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT00038558
Study Brief:
Protocol Section:
NCT00038558